Editorial: Predictive tools in pheochromocytoma and paraganglioma - PubMed (original) (raw)

Editorial

Editorial: Predictive tools in pheochromocytoma and paraganglioma

Filippo Ceccato et al. Front Endocrinol (Lausanne). 2023.

No abstract available

Keywords: endocrine neoplasms; paraganglioma; pheochromocytoma; predictive model; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

References

    1. Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep (2014) 16(7):442. doi: 10.1007/s11906-014-0442-z -DOI -PubMed
    1. Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Phaeochromocytoma. Lancet (2005) 366(9486):665–75. doi: 10.1016/S0140-6736(05)67139-5 -DOI -PubMed
    1. Grasso M, Boscaro M, Scaroni C, Ceccato F. Secondary arterial hypertension: from routine clinical practice to evidence in patients with adrenal tumor. High Blood Press Cardiovasc Prev (2018) 25(4):345–54. doi: 10.1007/s40292-018-0288-6 -DOI -PubMed
    1. Eisenhofer G. Reference intervals for plasma free metanephrines with an age adjustment for normetanephrine for optimized laboratory testing of phaeochromocytoma. Ann Clin Biochem Int J Lab Med (2013) 50(1):62–9. doi: 10.1258/acb.2012.012066 -DOI -PMC -PubMed
    1. Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab (2003) 88(6):2656–66. doi: 10.1210/jc.2002-030005 -DOI -PubMed

Publication types

MeSH terms

LinkOut - more resources